Merck & Co's Keytruda Disappoints In Small-Cell Lung Cancer

Triple-Negative Breast Cancer The Next Big Therapeutic Opportunity?

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.